| Literature DB >> 29577614 |
Yuliang Huang1, Haizhen Yue1, Meijiao Wang1, Sha Li1,2, Jian Zhang1, Zhuolun Liu1, Yibao Zhang1,3.
Abstract
PURPOSE: Eclipse treatment planning system has not been able to optimize the jaw positions for Volumetric Modulated Arc Therapy (VMAT). The arbitrary and planner-dependent jaw placements define the maximum field size within which multi-leaf-collimator (MLC) sequences can be optimized to modulate the beam. Considering the mechanical constraints of MLC transitional speed and range, suboptimal X jaw settings may impede the optimization or undermine the deliverability. This work searches optimal VMAT jaw settings automatically based on Eclipse Scripting Application Programming Interface (ESAPI) and RapidPlan knowledge-based planning. METHODS AND MATERIALS: Using an ESAPI script, the X jaws of rectal VMAT plans were initially set to conform the planning-target-volume (PTV), and were gradually extended toward the isocenter (PTV center) in 5-7 mm increments. Using these jaw pairs, 592 plans were automatically created for 10 patients and quantitatively evaluated using a comprehensive scoring function. A published RapidPlan model was evoked by ESAPI to generate patient-specific optimization objectives without manual intervention. All candidate plans were first stored as text files to save storage space, and only the best, worst, and conformal plans were consequently recreated for comparison.Entities:
Keywords: zzm321990ESAPIzzm321990; zzm321990VMATzzm321990; RapidPlan; jaw optimization; treatment planning
Mesh:
Year: 2018 PMID: 29577614 PMCID: PMC5978713 DOI: 10.1002/acm2.12313
Source DB: PubMed Journal: J Appl Clin Med Phys ISSN: 1526-9914 Impact factor: 2.102
Figure 1Plan scores and individual OAR scores of 100 candidate plans for the first patient using various jaw settings. The 26 clinically unacceptable plans with hot spots receiving over 107% of dose prescription are marked as “x”. The vertical dashed lines indicate the worst plan (orange, highest plan score = 3.02) and the best plan (blue, lowest plan score = 2.73), respectively. The conformal plan is the first plan on the left pointed by an arrow (plan score = 2.94).
Figure 2A heat map reflecting the sensitivity of plan scores to the X jaw sizes and locations for the first patient. Colder pixels indicate better OAR sparing, and the 26 clinically unacceptable cases were colored as uniform dark red. Increased absolute values of X1 and X2 axes indicate jaw retraction hence larger field sizes.
Figure 3Mean DVHs of 10 patients comparing the best (circle), worst (triangle), and conformal (square) plans as suggested by the scores. The urinary bladder, small bowel, and femoral head are indicated by red, blue, and green colors, respectively. The error bars indicate 1 standard deviation.
Dosimetric statistics of 100 candidate plans using various jaw settings
| Minimum | Maximum | Mean ± SD | Best | Worst | Conformal | |
|---|---|---|---|---|---|---|
| Small bowel | ||||||
| MDVP | 1721.50 | 2587.03 | 1963.71 ± 175.12 | 1845.54 | 2001.87 | 1924.78 |
| HDVP | 14.06 | 666.57 | 84.51 ± 118.07 | 28.57 | 37.86 | 75.18 |
| Score | 0.85 | 1.59 | 1.00 ± 0.14 | 0.91 | 0.99 | 0.98 |
| Femoral head | ||||||
| MDVP | 898.52 | 1187.79 | 1098.62 ± 66.26 | 1044.37 | 1140.44 | 1160.59 |
| HDVP | 0 | 17.24 | 1.09 ± 2.71 | 2.50 | 0 | 0 |
| Score | 0.82 | 1.08 | 1.00 ± 0.06 | 0.95 | 1.04 | 1.06 |
| Urinary bladder | ||||||
| MDVP | 1827.79 | 3523.41 | 2100.14 ± 371.26 | 1850.16 | 2161.90 | 1981.67 |
| HDVP | 345.38 | 1761.69 | 496.66 ± 286.81 | 380.63 | 409.56 | 380.63 |
| Score | 0.85 | 2.04 | 1.00 ± 0.25 | 0.86 | 0.99 | 0.91 |
Excluding 26 unacceptable plans.
Abbreviations: MDVP, mean dose volume product; HDVP, high dose volume product, where for small bowel, femoral head, and urinary bladder, the HDVP were calculated for the volumes receiving no less than 35, 40, and 40 Gy, respectively, per RTOG 0822 protocols.
Mean values ± 1SD of 10 patients’ best, worst, and conformal plans
| Best | Worst | Conformal |
| |
|---|---|---|---|---|
| Small bowel | ||||
| V35 | 2.8 ± 2.5 | 7.4 ± 7.9 | 4.9 ± 4.2 | 0.009 |
| V40 | 0.8 ± 0.9 | 3.0 ± 4.0 | 1.5 ± 2.1 | 0.126 |
| V45 | 0.1 ± 0.3 | 0.4 ± 1.1 | 0.2 ± 0.5 | 0.638 |
|
| 20.9 ± 3.5 | 24.7 ± 5.7 | 23.3 ± 4.5 | 0.003 |
| Femoral head | ||||
| V40 | 0.2 ± 0.2 | 0.3 ± 0.3 | 0.3 ± 0.2 | 0.130 |
|
| 12.1 ± 1.5 | 13.0 ± 1.9 | 12.7 ± 1.6 | 0.018 |
| Urinary bladder | ||||
| V40 | 7.4 ± 4.0 | 8.7 ± 7.5 | 7.8 ± 5.6 | 0.523 |
| V45 | 3.2 ± 2.7 | 3.6 ± 4.5 | 3.3 ± 4.0 | 0.980 |
| V50 | 0.4 ± 0.7 | 0.3 ± 0.4 | 0.4 ± 0.8 | 0.905 |
|
| 23.1 ± 3.8 | 25.0 ± 5.8 | 24.1 ± 5.2 | 0.102 |
Abbreviations: VD means relative volume (%) receiving dose no less than D Gy. means mean dose (Gy). P represents the P‐value of paired comparison between the best and conformal plans. Other RTOG 0822 recommended metrics <0.1 were not reported.